CannabIP: U.S. Patent No. 10,265,362 B2

Cannabis IP patent

U.S. Patent No. 10,265,362 B2 (‘362) issued on April 23, 2019, for “Ingestible Films Having Substances From Hemp or Cannabis.”  It was issued to applicant/inventor Scott Schaneville, of St. Petersburg, Florida. Figure 1-2 illustrates the claimed invention: The ‘362 patent discloses a new system for cannabis medical drug delivery, specifically through mucosal oral administration of …

Continue Reading

SCOTUS Watch: Bar on Immoral and Scandalous Marks Violates First Amendment

1st amendment scotus watch section 2(a) trademark

On June 24, 2019, the U.S. Supreme Court handed down Iancu v. Brunetti,[1] dealing with the Lanham Act’s Section 2(a) bars to trademark registration’s collision against the First Amendment brick wall; the Justices in a 6-3 vote struck down the immoral and scandalous clause of §2(a) in a somewhat mixed-up and divided Court.  Brunetti is …

Continue Reading

CannabIP: Second Circuit Refuses to Dismiss CBD Reclassification Case

Cannabis IP patent trademark

On May 30, 2019, the Court of Appeals for the Second Circuit in Washington v. Barr,[1] refused to dismiss outright a case where the plaintiffs alleged marijuana’s classification on the Drug Enforcement Agency (DEA)’s Schedule I list of the Controlled Substance Act (CSA) of the poses a “serious, life-of-death threat to their health.”  The Second …

Continue Reading

CannabIP: Hemp Now Accepted For PVP Protection

Cannabis IP plantIP PVP technology

On April 24, 2019, the U.S. Department of Agriculture (USDA) announced that the Plant Variety Protection Office (PVPO) will begin accepting applications for new, distinctive hemp-based seed-propagated plants for Plant Variety Protection (PVP) Certificates, as a result of the 2018 Farm Bill signed December 20, 2018.  Hemp is the non-psychoactive element of C. sativa plant, …

Continue Reading

TechPat: Justice Department Reviews Truvada Manufacturer for Possible Patent Violations

patent Tech Patents

The U.S. Department of Justice (DOJ) has recently opened an investigation into possible violations of Gilead Sciences, Inc.’s exclusive license with the U.S. Government of its blockbuster HIV drug, TRUVADA®.  Truvada is the pre-exposure prophylaxis (PrEP) which has been shown to prevent HIV infections.  Because of its exclusive license, Gilead is the only manufacturer of …

Continue Reading

CannabIP: U.S. Patent No. 10,179,694 B2

Cannabis IP patent

U.S. Patent No. 10,179,694 B2 (‘694) issued on November 20, 2018, for “Constant Illuminated Tamper-Resistant Plant Shipping Container.”  It was issued to applicant/inventor Larry D. Fenner, Jr. of Bellingham, Washington.  The assignee is THC Acquisition Corp. of Kelowna, British Columbia.  THC BioMed Ltd. is the parent company, a Canadian medical cannabis company. Figure 1 illustrates …

Continue Reading

Fed Circuit Watch: EV Battery Claims Found Patent-Ineligible

101 fed circuit watch patent patent eligible subject matter

What had opened with a promise of clarity for patent subject matter eligibility under 35 U.S.C. §101 took a detour with the ChargePoint, Inc. v. SemaConnect, Inc.,[1] decision issued on March 28 2019, by the Court of Appeals for the Federal Circuit. Four patents were at-issue, all owned by ChargePoint: U.S. Patent Nos. 8,138,715 (‘715), …

Continue Reading